# Web Search Evidence

> Connector: `web-search-1` (Tavily). This page records compact, relevant evidence from the 2026-07-26 pull; search results are discovery leads, not vendor-confirmed announcements.

## 2026-07-26 pull

### 3D spheroid automation and assay standardization — source-backed

- **Nature, published 2026-07-21:** [Automation of 3D liver spheroid generation and acetaminophen dose–response on the MO:BOT enhances assay robustness and precision](https://www.nature.com/articles/s41598-026-58939-4). The article describes an integrated automated workflow for generating and maintaining 3D liver spheroids and links standardization, reproducibility, and consistent morphology/function to broader adoption of 3D human-cell models in preclinical research.
- **Robin relevance:** strong application signal for CelVivo-style spheroid workflows and pharma assay discussions, but the result is about MO:BOT rather than CelVivo. Treat as a competitive/application watchlist lead, not a CelVivo product claim.
- **Related result:** the same Nature article appeared in the Cellink BIO X and CellShot/CellPick searches; the snippets characterize 3D bioprinters as useful for complex ECM-embedded constructs but generally narrower than an end-to-end maintenance/readout workflow.

### Organ-on-chip and preclinical translation — watchlist

- **Nature, published 2026-07-23:** [Engineering human Gut-on-a-Chip culturomics for predictive pharmacomicrobiomics of first-pass metabolism](https://www.nature.com/articles/s44385-026-00099-1). Tavily's result highlights intestinal first-pass metabolism and pharmacokinetic differences for orally administered drugs.
- **GeneOnline, published 2026-07-26:** [Next-Gen Preclinical Translation: Non-Animal Methods, Humanized Mouse Models, and AI Integration](https://www.geneonline.com/bio-asia-taiwan-2026-next-gen-preclinical-translation-july-007-report/). The snippet frames organ-on-a-chip, NAMs, humanized models, and predictive AI as part of current preclinical translation work.
- These are relevant to Robin's organ-on-chip/pharma lane, but the pull provides no customer, vendor, or regulatory action. Keep as watchlist evidence.

### 3Brain / neuroscience search lane — no direct product confirmation

- The strongest result was a 2026-07-24 *Scientific Reports* article on a portable semi-dry EEG device for brain-computer-interface applications ([Nature link](https://www.nature.com/articles/s41598-026-52672-8)); it does not identify 3Brain CorePlate or MEA chips. Do not promote it as 3Brain evidence.

### Cellink, Femtobiomed, and workflow tooling

- The pull produced no credible direct Cellink BIO X/BIONOVA X/Lumen X announcement, no CellShot/CellPick/TriArm result, and no Hermes/OpenWiki/RAGFlow ecosystem result.
- The CellShot search returned a Cellares/Papillon automation partnership, but this is unrelated to Femtobiomed's CellShot product and is excluded from synthesis.

## Evidence handling

- Search results are single-source discovery evidence; vendor-specific claims require direct vendor or independent corroboration before being labeled `confirmed` or `source-backed`.
- Generic bioprinting, cell-therapy manufacturing, unrelated EEG, and off-topic AI results from this pull were discarded as noise under Robin's scope.

## Source coverage

- Fetched: 2026-07-26T17:39:11Z
- Queries: 10
- Instance: `web-search-1`
- Raw evidence: `~/.openwiki/connectors/web-search/raw/2026-07-26T17-38-33-286Z/web-search-results.json`